Roche Diagnostics

Antibody Testing: FDA performance data shows reliability for new Roche test

A breakthrough for moms and babies. Preeclampsia can be unpredictable — and in some cases, life-threatening. But now, a new FDA-cleared blood test can help doctors predict the risk within two weeks, giving families answers sooner and helping prevent unnecessary early deliveries. This innovation is changing how preeclampsia is detected and managed — supporting healthier outcomes for moms and their babies: go.roche.com/Preeclampsia_Blood_Test | Roche Diagnostics USA

Roche Diagnostics

Roche Diagnostics - Transforming the way diseases can be prevented, diagnosed and monitored